Apogee Therapeutics (APGE) leverages IL-13 pathway optimization to enable less frequent dosing, targeting a leadership shift in biologic treatment for inflammatory diseases. APGE's $913 million cash ...

MINNEAPOLIS--(BUSINESS WIRE)-- Apogee Enterprises, Inc. (APOG) announced today the resignation of Matthew J. Osberg as Chief Financial Officer. Mr. Osberg is leaving Apogee to pursue another ...

MINNEAPOLIS - Apogee Enterprises, Inc. (NASDAQ:APOG) announced Wednesday that Chief Financial Officer Matthew J. Osberg has resigned to pursue another professional opportunity. Osberg will remain with ...

Apogee missed on Q2 sales this morning, and warned of an earnings miss this year. Apogee stock pays a nice dividend and costs less than 10x this year's earnings. Apogee Enterprises (NASDAQ: APOG) ...

Architectural products company Apogee (NASDAQ:APOG) will be reporting results tomorrow before the bell. Here’s what to expect. Apogee beat analysts’ revenue expectations by 2.1% last quarter, ...

The Nox Sidereal IV is the newest addition to the Aggressive Frame Fusion Rifle arsenal in Destiny 2. While the archetype family was once known for being the weak link, Bungie implemented some reworks ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The board will immediately begin ...

Apogee Enterprises' chief executive, Ty Silberhorn, is leaving the architectural products and services company. Apogee on Friday said its independent chairman, Donald Nolan, will now serve as ...

The company aims to raise gross proceeds of roughly $300 million in a new capital-raising effort. Apogee, a clinical-stage biotech that focuses on immunology and inflammation disorders, announced a ...

A solar day is defined by the Sun's return to the local meridian, while a sidereal day is defined by the return of the March equinox to the local meridian. A solar day is approximately 3 minutes and ...

Apogee Therapeutics on Monday said an experimental antibody drug it’s developing significantly reduced signs and symptoms of atopic dermatitis, a common form of eczema, when compared to a placebo in a ...